Lars Frykberg

Title: Lars Frykberg: Innovator in Biotechnology

Introduction

Lars Frykberg is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic and diagnostic applications. His work has the potential to impact medical diagnostics and treatment strategies.

Latest Patents

Lars Frykberg holds a patent for a fibrinogen binding protein originating from coagulase-negative staphylococcus. This invention includes a new fibrinogen binding protein or polypeptide, biotechnological methods for producing the protein or polypeptide with fibrinogen binding activity, and a recombinant DNA molecule coding for the protein or its fragments. The patent also covers micro-organisms, including viruses, that contain this recombinant DNA molecule. Furthermore, the invention encompasses therapeutic and diagnostic uses of the protein and/or DNA, such as a diagnostic kit for determining the presence and/or type of coagulase-negative staphylococci and a vaccine composition that includes the protein or DNA.

Career Highlights

Throughout his career, Lars Frykberg has focused on innovative solutions in biotechnology. His work has led to advancements in understanding and utilizing fibrinogen binding proteins, which are crucial for various medical applications. His patent reflects his commitment to enhancing diagnostic and therapeutic methods in healthcare.

Collaborations

Lars Frykberg has collaborated with notable colleagues in his field, including Bengt Mikael Guss and Jan-Ingmar Flock. These collaborations have contributed to the development of his innovative ideas and the successful realization of his patent.

Conclusion

Lars Frykberg is a distinguished inventor whose work in biotechnology has the potential to revolutionize medical diagnostics and treatments. His patent for a fibrinogen binding protein showcases his innovative spirit and dedication to advancing healthcare solutions.